Successful strategy for merge and acquisition

Consolidation and convergence will likely be accelerating across the domestic pharmaceutical industry within a couple of years in the changing business environment of the 21st century, but Korean firms are still showing a passive attitude towards mergers and acquisitions (M&As) due to the lack of experience and fear of possible failures, according to pharmaceutical business sources.

As many ...